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Background: Diabetes is a recognized risk factor for cardiovascular (CV) disease associated with adverse outcomes in patients with acute 
coronary syndromes. However, the impact of diabetes on in-hospital CV morbidity and mortality has not been well described in large national 
populations with acute myocardial infarction (AMI).
Methods: Data were analyzed from 232,927 National Registry of Myocardial Infarction (NRMI 4-5) patients hospitalized for AMI, from July 2002 to 
December 2006. Multivariable logistic regression analyses were conducted to evaluate the association between history of diabetes and in-hospital 
adverse outcomes for all-cause mortality and recurrent MI (MI covariate adjustments included demographic characteristics, prior medical history, 
AMI characteristics and pre-admission medications). The interaction between diabetes and history of prior MI was also tested.
Results: History of diabetes was reported in 31% of the patient cohort. Females represented a greater proportion of diabetic patients (45%) 
than non-diabetic patients (39%). ST-segment elevation MI occurred in 31% of patients with diabetes and 40% of those without. There was higher 
reported use of pre-admission CV medications in patients with diabetes, including angiotensin-converting enzyme inhibitors/angiotensin receptor 
blockers, lipid-lowering agents, antiplatelet agents and beta blockers. Patients with a history of diabetes had an increased risk of in-hospital 
mortality (adjusted odds ratio [OR]=1.18; 95% confidence interval [CI] 1.13-1.23) and recurrent MI (adjusted OR=1.14; 95% CI 1.05-1.24). There 
was a significant interaction between reported diabetes and prior MI for length of stay; those with both had nearly one day longer length of stay than 
those with neither.
Conclusion: Patients with diabetes presenting with an AMI were at increased risk of subsequent in-hospital adverse events, including mortality and 
recurrent MI. Increased morbidity and mortality in these patients may translate to additional burden on the hospital system. These findings highlight 
the need for optimal medical management and new treatment options to prevent adverse CV events in patients with diabetes and AMI.
